| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 10/21/2004 | US20040209825 Inhibition by 3-deoxyflavonoids of T-lymphocyte activation and therapies related thereto |
| 10/21/2004 | US20040209822 Novel compounds |
| 10/21/2004 | US20040209813 Caspase inhibitors for inhibiting blood cell proliferation and for treating autoimmune diseases |
| 10/21/2004 | US20040209806 controlling trefoil factor-2 (TFF2) expression; for reducing acid secretion and/or increasing epithelial cell proliferation to promote healing; lung assessment |
| 10/21/2004 | US20040209799 comprises inhibitors (cytokines) of janus kinases (JAK)/signal transducers and activators of transcription (STAT) other than debromohymenialdisine and hymensialdisine; gene expression inhibition; bioassay, immunoassay, drug screening; for treatment of degenerative joint diseases such as osteoarthritis |
| 10/21/2004 | US20040209798 biodrugs for treatment of lung cancer, glioma, anorexia, hypothyroidism, hyperaldosteronism, H. pylori proliferation, acromegaly, restenosis, Crohn's disease, systemic sclerosis, external and internal pancreatic pseudocysts and ascites |
| 10/21/2004 | US20040208944 Compositions and methods against inflammatory processes |
| 10/21/2004 | US20040208924 active pharmaceutical ingredient is for example [(2S)-Sulfanyl-5-[(N,N-dimethylamino)acetyl]aminopentanoyl-L-leucyl-L-tert-leucine N-methylamide; bonding strength, stability |
| 10/21/2004 | US20040208895 administering HETEROLOGOUS GENE PRODUCTS IN HOST CELL SYSTEMS AND/OR TO RESCUE NEGATIVE STRAND RNA RECOMBINANT VIRUSES |
| 10/21/2004 | US20040208894 compositions with dead E. coli; for treating or preventing undesirable allergic reactions and anaphylactic allergic reactions to allergens in a subject. rectal administration |
| 10/21/2004 | US20040208857 Producing a donor-specific immunotolerance against transplanted tissue by administering embryonic stem cell-like cell lines (ECL) obtained from blastocysts and are transfected with genetic material of the donor, which codes for the major histocompatibility complex (MHC) haplotypes |
| 10/21/2004 | DE102004016947A1 Feste pharmazeutische Zusammensetzung A solid pharmaceutical composition |
| 10/21/2004 | DE102004010690A1 Gesundheitsfördernde Zusammensetzungen aus lipidhaltigen Pilzen und Thiocyanaten Health-promoting compositions of lipid-containing mushrooms and thiocyanates |
| 10/21/2004 | CA2707750A1 Solid pharmaceutical compositions comprising a s1p receptor agonist and a sugar alcohol |
| 10/21/2004 | CA2523186A1 Method of screening drug with the use of 67 kda laminin receptor and drug obtained thereby |
| 10/21/2004 | CA2522456A1 Nucleotide and cellular vaccine composition |
| 10/21/2004 | CA2521602A1 Therapeutic composition for autoimmune conditions |
| 10/21/2004 | CA2521340A1 Aminopyrimidine derivatives and their medical use |
| 10/21/2004 | CA2520865A1 Zwitterionic immunomodulators for the treatment of asthma and allergy |
| 10/20/2004 | EP1469065A1 Composition of antibody specifically binding to cd20 |
| 10/20/2004 | EP1469000A1 Novel crystalline tricyclic triazolobenzazepine derivative |
| 10/20/2004 | EP1468991A1 Imides as PDE III, PDE IV and TNF inhibitors |
| 10/20/2004 | EP1468682A1 Therapeutic combinations comprising amlodipine and atorvastatin |
| 10/20/2004 | EP1468097A2 METHODS OF GENERATING MULTISPECIFIC, MULTIVALENT AGENTS FROM V sb H /sb AND V sb L /sb DOMAINS |
| 10/20/2004 | EP1468091A2 Transmembrane protein |
| 10/20/2004 | EP1468020A2 Multimers of receptor-binding ligands |
| 10/20/2004 | EP1468019A2 Secreted protein |
| 10/20/2004 | EP1468018A2 Leptin proteins |
| 10/20/2004 | EP1468012A1 Biomolecule transduction motif mph-1-btm and the use thereof |
| 10/20/2004 | EP1468011A1 Biomolecule transduction motif sim-2-btm and the use thereof |
| 10/20/2004 | EP1467997A1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group |
| 10/20/2004 | EP1467995A2 Pyrrolopyrimidine a2b selective antagonist compounds, their synthesis and use |
| 10/20/2004 | EP1467982A1 Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them, and uses thereof |
| 10/20/2004 | EP1467979A2 FUSED HETEROCYCLIC COMPOUNDS AND ANALOGS THEREOF: MODULATORS OF NUCLEAR HORMONE RECEPTOR FUNCTION |
| 10/20/2004 | EP1467976A1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
| 10/20/2004 | EP1467972A1 Indazole compounds useful as protein kinase inhibitors |
| 10/20/2004 | EP1467965A1 N-(4-substituted phenyl)-anthranilic acid hydroxamate esters |
| 10/20/2004 | EP1467764A1 Statins (hmg-coa reductase inhibitors) as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent |
| 10/20/2004 | EP1467763A1 Methods for treatment of multiple sclerosis with statins |
| 10/20/2004 | EP1467752A1 HUMAN MAST CELL−EXPRESSED MEMBRANE PROTEINS |
| 10/20/2004 | EP1467745A2 Herbal composition for treating various disorders including psoriasis, a process for preparation thereof and method for treatment of such disorders |
| 10/20/2004 | EP1467741A1 Pharmaceutically acceptable phosphate-glycerol carrying bodies |
| 10/20/2004 | EP1467740A1 Phospholipid bodies and use thereof in the treatment of inflammatory and autoimmune diseases |
| 10/20/2004 | EP1467721A2 Substituted amine derivatives and their use for the treatment of angiogenesis |
| 10/20/2004 | EP1467714A1 Drug mixture with enhanced dissolution rate |
| 10/20/2004 | EP1467711A2 Dna dosage forms |
| 10/20/2004 | EP1263725B1 Novel compounds |
| 10/20/2004 | EP1233954B1 A process for the preparation of 2- 4-(alpha-phenyl-p-chlorobenzyl)piperazin-1-yl]ethoxy acetic acid and novel intermediates therefor |
| 10/20/2004 | EP1230236B1 Compound with growth hormone releasing properties |
| 10/20/2004 | EP1217902B1 Nutritional compositions which contain non-digestible polysaccharides and use thereof to reduce transport through tight junctions |
| 10/20/2004 | EP1181381B1 Organ, tissue and cell-specific immuno-therapeutic for chronic viral infections and inflammatory, degenerative and proliferative diseases, in particular of the liver, and for cancer, based on a recombinant parapox virus |
| 10/20/2004 | EP1149074B1 Acetylenic sulfonamide thiol tace inhibitors |
| 10/20/2004 | EP0886528B1 Use of coxiella bacteria to treat autoimmune disease |
| 10/20/2004 | EP0658113B1 Isolated nonapeptide derived from mage-3 gene and presented by hla-a1, and uses thereof |
| 10/20/2004 | CN1539010A Fermentation product of cryptoporus volvatus and its preparation method and application |
| 10/20/2004 | CN1538970A Thieno [2,3-d] pyrimidinediones and use in modulation of autoimmune disease |
| 10/20/2004 | CN1538960A Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containint them |
| 10/20/2004 | CN1538959A Fused-polycyclic compounds |
| 10/20/2004 | CN1538951A Omega-aminoalkylamides of R-2-aryl-propionic acids as inhibitors of chemotaxis of polymorphonucleate and mononucleate cells |
| 10/20/2004 | CN1538853A T cell regulatory genes and methods of use thereof |
| 10/20/2004 | CN1538844A Novel amides preparation used as modulators of CCR-receptor activity, its preparation and therapeutic use |
| 10/20/2004 | CN1538836A Substituted amine derivatives and method of use |
| 10/20/2004 | CN1537619A Traditional Chinese medicine for immunity and strengthening the body resistance |
| 10/20/2004 | CN1537537A Method for preparing nucleic acid hydrolysate contained in Heluo (nucleic junket) oral liquid |
| 10/20/2004 | CN1537531A Celecoxib compositions |
| 10/20/2004 | CN1171889C Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of P38 protein kinase |
| 10/20/2004 | CN1171883C Nonsteroidal antiinflammatories |
| 10/20/2004 | CN1171637C Vaccine against nepatitis B Birus and human papilloma virus |
| 10/20/2004 | CN1171633C Cordyceps capsule and its preparation method |
| 10/20/2004 | CN1171631C Gamma & T cell immunoactivity potentiators containing shiitake mushroom hypha extract |
| 10/20/2004 | CN1171630C LAK activity potentiator orginating in shiitake mushroom hyphae extract and LAK activty potentiating preparations containing the same |
| 10/20/2004 | CN1171619C Health-care food with fatigue resistance, regulating immunologic function and its preparation method |
| 10/20/2004 | CN1171591C Composite melatonin and its preparing process |
| 10/20/2004 | CN1171583C Medical percutaneous preparation containing hydrophilic or salt form |
| 10/19/2004 | US6806370 NK-1 receptor active amine oxide prodrugs |
| 10/19/2004 | US6806312 Thermoplastic resin composition |
| 10/19/2004 | US6806287 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
| 10/19/2004 | US6806276 2-oxoquinoline compounds and pharmaceutical uses thereof |
| 10/19/2004 | US6806274 Quinazoline derivatives |
| 10/19/2004 | US6806262 2-ethyl and 2-ethylidene-19-nor-vitamin D compounds |
| 10/19/2004 | US6806261 Control release transforming growth factor; central nervous system disorders; antiproliferative agent |
| 10/19/2004 | US6805863 Comprises antibodies/proteins providing inhibition of prothrombinase; treatment and prevention of bacterial and viral infections, allograft/xenograft rejection, glomerulo-nephritis, cancer, gastrointestinal diseases, and fetal loss |
| 10/19/2004 | US6805854 Delivery of sumatriptan, frovatriptan or naratriptan through an inhalation route |
| 10/14/2004 | WO2004087915A1 Seb modification and preventive/remedy for diseases with immune abnormality contianing the same |
| 10/14/2004 | WO2004087899A1 Method for obtaining regulating dendritic cells and t cells |
| 10/14/2004 | WO2004087763A1 Modified antibody against cd22 and utilization thereof |
| 10/14/2004 | WO2004087747A2 Citrullinated synthetic peptides and uses thereof |
| 10/14/2004 | WO2004087699A2 Thiazoles useful as inhibitors of protein kinases |
| 10/14/2004 | WO2004087698A2 Thiazoles useful as inhibitors of protein kinases |
| 10/14/2004 | WO2004087679A1 2, 4, 6-trisubstituted pyrimidine derivatives useful for the treatment of neoplastic and autoimmune diseases |
| 10/14/2004 | WO2004087210A1 Method of inducing differentiation and proliferating regulatory t cell by anti-cd52 antibody and medicinal composition therefor |
| 10/14/2004 | WO2004087203A2 Immunostimulatory nucleic acid oil-in-water formulations for topical application |
| 10/14/2004 | WO2004087202A2 Pharmaceutical composition comprising a macrolide immunomodulator |
| 10/14/2004 | WO2004087195A2 Therapeutic use of modulators of notch and/or kruppel-like factors |
| 10/14/2004 | WO2004087188A1 Histamine binding compounds for treatment method for disease conditions mediated by neutrophils |
| 10/14/2004 | WO2004087187A1 Method of enhancing autoimmunity |
| 10/14/2004 | WO2004087181A2 ACTIVE INGREDIENT COMBINATIONS OF PLANT OILS CONTAINING ω3-FATTY ACIDS AND PLANT EXTRACTS CONTAINING POLYPHENOLS AND THE USE THEREOF |
| 10/14/2004 | WO2004087129A1 Composition for preventing or treating allergic disease using black rice extract and its therapeutic use |
| 10/14/2004 | WO2004046182A3 Use of soluble forms of cd83 and nucleic acids encoding them for the treatment or prevention of diseases |
| 10/14/2004 | WO2004016769A3 Antibodies directed to monocyte chemo-attractant protein-1 (mcp-1) and uses thereof |